<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001928391</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001341235</issuerCik>
      <issuerName>Aldeyra Therapeutics, Inc.</issuerName>
      <secFileNumber>001-36332</secFileNumber>
      <issuerAddress>
        <com:street1>131 HARTWELL AVENUE</com:street1>
        <com:street2>SUITE 320</com:street2>
        <com:city>LEXINGTON</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02421</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>781-761-4904</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Greenberg Bruce</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Morgan Stanley Smith Barney LLC</name>
        <address>
          <com:street1>1 New York Plaza</com:street1>
          <com:street2>8th Floor</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10004</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>10834</noOfUnitsSold>
      <aggregateMarketValue>55253.40</aggregateMarketValue>
      <noOfUnitsOutstanding>59421551</noOfUnitsOutstanding>
      <approxSaleDate>08/12/2024</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>07/15/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock Unit Award</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>126087</amountOfSecuritiesAcquired>
      <paymentDate>07/15/2022</paymentDate>
      <natureOfPayment>Services rendered</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>08/12/2024</noticeDate>
      <signature>/s/ Bruce Greenberg</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2842}]
144
0001928391
XXXXXXXX
LIVE
0001341235
Aldeyra Therapeutics, Inc.
001-36332
131 HARTWELL AVENUE
SUITE 320
LEXINGTON
MA
02421
781-761-4904
Greenberg Bruce
Officer
Common Stock
Morgan Stanley Smith Barney LLC
1 New York Plaza
8th Floor
New York
NY
10004
10834
55253.40
59421551
08/12/2024
Nasdaq
Common Stock
07/15/2022
Restricted Stock Unit Award
Issuer
N
126087
07/15/2022
Services rendered
Y
08/12/2024
/s/ Bruce Greenberg